This lysate is prepared as a positive control for separation by SDS-PAGE and subsequent Western blot analysis. Lysates are prepared in denaturing buffer WITHOUT reducing agents (i.e. 2-mercaptoethanol (BME) or dithiothreitol (DTT)). If reducing conditions are desired, add a reducing agent prior to heating. Heat lysate to 95 degrees C for 5 minutes and rapidly cool. The recommended loading amount is 0.01-0.03 mg per lane.
Read 1 Review rated 4 using NBP1-42569 in the following application:
FAQs for HepG2 Lysate (NBP1-42569). (Showing 1 - 2 of 2 FAQ).
How was this lysate prepared? Please advise as I am trying to use this material as a control lysate for a kit I purchased.
This lysate was prepared using standard RIPA buffer with 0.1% Triton X-100, and 1% SDS and sodium deoxycholate. We used mechanical separation to remove the cells from the plate and also use a cocktail of protease and phosphatase inhibitors in the lysate buffer.
Good morning, we have to work with short-HepG2 Whole Cell Lysate 1.0mg to do adsorb on nanoparticles. We are chemical-physical. I would like to know if the sample handling under the hood (not flow alminare) will have a biohazard and what precautions should be taken.
NBP1-42569 is a whole cell lysate with the cells in a RIPA buffer. These cells are lysed and not longer viable. They are not considered a biohazard and no special precautions need to be taken.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.